- Home
- ABT
as 12-20-2024 4:00pm EST
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
| Founded: | 1888 | Country: | United States |
| Employees: | N/A | City: | ABBOTT PARK |
| Market Cap: | 204.9B | IPO Year: | N/A |
| Target Price: | $129.80 | AVG Volume (30 days): | 4.7M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.29 | EPS Growth: | 12.04 |
| 52 Week Low/High: | $99.71 - $121.64 | Next Earning Date: | 01-22-2025 |
| Revenue: | $41,217,000,000 | Revenue Growth: | 3.15% |
| Revenue Growth (this year): | 5.73% | Revenue Growth (next year): | 7.17% |
Stock Insider Trading Activity of Abbott Laboratories (ABT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ALLEN HUBERT L | ABT | EXECUTIVE VICE PRESIDENT | Oct 21 '24 | Sell | $117.98 | 157,421 | $18,424,298.42 | 340,978 |
Latest Abbott Laboratories News
ABT Breaking Stock News: Dive into ABT Ticker-Specific Updates for Smart Investing
MT Newswires
15 hours ago
TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $130, Keeps Buy Rating
Zacks
21 hours ago
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories
Zacks
2 days ago
4 Healthcare Technology Innovators to Invest in Before the New Year
Zacks
2 days ago
Reasons to Retain ABT Stock in Your Portfolio Now
Motley Fool
2 days ago
2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond
Zacks
3 days ago
ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker
MT Newswires
3 days ago
RBC Raises Price Target on Abbott Laboratories to $135 From $130, Keeps Outperform Rating
Motley Fool
3 days ago
The Smartest Dividend Stocks to Buy With $500 Right Now
Compare ABT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABT Abbott Laboratories - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.